Featured Article
Month: June 2010
Avastin/Lucentis Update 41: The Story Behind the Invention of Avastin and Lucentis
Several months ago, I received a request from a university student writing a paper about Lucentis and Avastin. She asked about the references I had used in my first writeup on the two drugs. I sent her a copy of the reference and she used several quote…
Ellex 2RT Updated Clinical Results: ARVO 2010
Following up on my April 19th writeup (ELLEX 2RT Retinal Regeneration Laser: An Update – First Clinical Results), a report on the first clinical results from the trials being undertaken in London, here are the first results of some key pilot studies …
New CME Activity: Rethinking Ocular Antiinfectives, Issue I
Featured Article
Cheap and Easy Eye Tests On Your Cell Phone
Researchers at MIT have developed a method of using a basic cell phone coupled with a cheap and simple plastic device clipped onto the screen to estimate refractive errors and focal range of eyes. Because of its simplicity and the fact that soon just …
Webinar: Blood Vessel Growth and Maturation
Featured Article
Avastin/Lucentis Update 40: Lucentis is Approved for Treating Macular Edema in Retinal Vein Occlusion
According to an announcement from Genentech, Lucentis has been approved by the FDA for treating macular edema following retinal vein occlusion (RVO)Here is Genentech’s news release:FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for the Tr…
Menu – Part 16: Updates for April to June 2010
Since the last menu posting in late March, I have added three updates on Avastin vs. Lucentis; five updates on AMD topics; one CATT update; and two new postings. One new posting is an update on the Ellex 2RT treatment, including the first clinical resu…
Avastin/Lucentis Update 39: And the Controversy Continues
This article was published in yesterday’s Wall Street Journal. It again illustrates how Medicare operates with one hand tied behind its back.Medicare Eye Study Finds Untapped SavingsWSJ, June 17, 2010By Alicia MundyMedicare could save more than $500 …
Retinal Disease Progression: Immediate Treatment vs Watchful Waiting
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!
In this video commentary, Dr. David Brown offers advice regarding time to treatment of the different types of retinal disease entities.
The Right Decision: Accurate and Effective Preoperative Evaluation of LASIK Candidates
Technology Spotlight
A Proud Heritage: European Ophthalmologists Pioneering LASIK
Technology Spotlight
Medscape One on One: The Surgeon General Takes the Lead in the Fight Against Obesity
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!Visit me on Facebook for ad-free browsing through 2011!
Dr. Adashi interviews Surgeon General Dr. Regina Benjamin on the problem of o…
Ophthalmic Surgical Dyes: VisionBlue and MembraneBlue
Technology Spotlight
CATT Study Update 11: More on the Story Behind the Story of the CATT Study
As we await publication of the first results of the CATT Study, probably sometime early next year, I found another interesting account of the “story behind the story” of how the CATT Study became a reality. Just published by the Health Care Reform …
Femtosecond Lasers: Improving Refractive Outcomes Beyond 20/20
Technology Spotlight
The Internship Year: Critical Requirement or Irrelevant Time Commitment for Ophthalmology?
Featured Article
The Cloudy Cornea: A Case Report
Featured Article
Pressure-Independent Approaches to the Treatment of Glaucoma
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!
Is neuroprotection a viable treatment option for glaucoma? Drs. Robert Weinreb, Jay Katz, and Theodore Krupin explore the possibilit…
Anti-VEGF Therapy and Beyond: The Future of Retinal Disease Treatment
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!
Anti-VEGF therapy is a significant breakthrough in the treatment of retinal disease; however, Dr. David Brown stresses the importanc…